Cabozantinib with nivolumab for untreated advanced renal cell carcinoma

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 17 MB)

  Published:

  10 April 2024

• Final draft guidance committee papers (PDF 6.82 MB)

  Published:

  10 April 2024

• Economic analysis

• Renal cell carcinoma pathway model report